BioNTech Stock Forecast - Double Exponential Smoothing

BNTX Stock  USD 88.09  0.40  0.45%   
The Double Exponential Smoothing forecasted value of BioNTech SE on the next trading day is expected to be 87.96 with a mean absolute deviation of  1.13  and the sum of the absolute errors of 67.99. BioNTech Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast BioNTech stock prices and determine the direction of BioNTech SE's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of BioNTech's historical fundamentals, such as revenue growth or operating cash flow patterns. Although BioNTech's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of BioNTech's systematic risk associated with finding meaningful patterns of BioNTech fundamentals over time.
Check out Historical Fundamental Analysis of BioNTech to cross-verify your projections.
  
At this time, BioNTech's Fixed Asset Turnover is fairly stable compared to the past year. Asset Turnover is likely to rise to 0.32 in 2024, whereas Inventory Turnover is likely to drop 1.59 in 2024. . Net Income Applicable To Common Shares is likely to rise to about 12.4 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 229.1 M in 2024.

Open Interest Against 2024-05-17 BioNTech Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast BioNTech's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in BioNTech's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for BioNTech stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current BioNTech's open interest, investors have to compare it to BioNTech's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of BioNTech is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in BioNTech. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in BioNTech cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the BioNTech's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets BioNTech's price structures and extracts relationships that further increase the generated results' accuracy.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for BioNTech works best with periods where there are trends or seasonality.

BioNTech Double Exponential Smoothing Price Forecast For the 26th of April

Given 90 days horizon, the Double Exponential Smoothing forecasted value of BioNTech SE on the next trading day is expected to be 87.96 with a mean absolute deviation of 1.13, mean absolute percentage error of 2.18, and the sum of the absolute errors of 67.99.
Please note that although there have been many attempts to predict BioNTech Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BioNTech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

BioNTech Stock Forecast Pattern

Backtest BioNTechBioNTech Price PredictionBuy or Sell Advice 

BioNTech Forecasted Value

In the context of forecasting BioNTech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. BioNTech's downside and upside margins for the forecasting period are 86.39 and 89.53, respectively. We have considered BioNTech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
88.09
87.96
Expected Value
89.53
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of BioNTech stock data series using in forecasting. Note that when a statistical model is used to represent BioNTech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.2278
MADMean absolute deviation1.1332
MAPEMean absolute percentage error0.0123
SAESum of the absolute errors67.989
When BioNTech SE prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any BioNTech SE trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent BioNTech observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for BioNTech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioNTech SE. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioNTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
86.2687.8489.42
Details
Intrinsic
Valuation
LowRealHigh
79.28104.22105.80
Details
Bollinger
Band Projection (param)
LowMiddleHigh
87.7888.2088.62
Details
19 Analysts
Consensus
LowTargetHigh
137.50151.10167.72
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BioNTech. Your research has to be compared to or analyzed against BioNTech's peers to derive any actionable benefits. When done correctly, BioNTech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BioNTech SE.

Other Forecasting Options for BioNTech

For every potential investor in BioNTech, whether a beginner or expert, BioNTech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BioNTech Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BioNTech. Basic forecasting techniques help filter out the noise by identifying BioNTech's price trends.

BioNTech Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioNTech stock to make a market-neutral strategy. Peer analysis of BioNTech could also be used in its relative valuation, which is a method of valuing BioNTech by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

BioNTech SE Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of BioNTech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of BioNTech's current price.

BioNTech Market Strength Events

Market strength indicators help investors to evaluate how BioNTech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioNTech shares will generate the highest return on investment. By undertsting and applying BioNTech stock market strength indicators, traders can identify BioNTech SE entry and exit signals to maximize returns.

BioNTech Risk Indicators

The analysis of BioNTech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BioNTech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biontech stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

BioNTech Investors Sentiment

The influence of BioNTech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in BioNTech. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to BioNTech's public news can be used to forecast risks associated with an investment in BioNTech. The trend in average sentiment can be used to explain how an investor holding BioNTech can time the market purely based on public headlines and social activities around BioNTech SE. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
BioNTech's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for BioNTech's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average BioNTech's news discussions. The higher the estimated score, the more favorable is the investor's outlook on BioNTech.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioNTech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioNTech's short interest history, or implied volatility extrapolated from BioNTech options trading.

Pair Trading with BioNTech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioNTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will appreciate offsetting losses from the drop in the long position's value.

Moving against BioNTech Stock

  0.72NRSNW NeuroSense TherapeuticsPairCorr
  0.62XFOR X4 Pharmaceuticals Earnings Call This WeekPairCorr
  0.62LLY Eli Lilly Earnings Call This WeekPairCorr
  0.6VKTX Viking Therapeutics Potential GrowthPairCorr
  0.58ELEV Elevation Oncology Earnings Call This WeekPairCorr
The ability to find closely correlated positions to BioNTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioNTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioNTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioNTech SE to buy it.
The correlation of BioNTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioNTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioNTech SE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioNTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock:
Check out Historical Fundamental Analysis of BioNTech to cross-verify your projections.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for BioNTech Stock analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is BioNTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNTech. If investors know BioNTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.80)
Earnings Share
4.08
Revenue Per Share
15.873
Quarterly Revenue Growth
(0.65)
Return On Assets
0.0262
The market value of BioNTech SE is measured differently than its book value, which is the value of BioNTech that is recorded on the company's balance sheet. Investors also form their own opinion of BioNTech's value that differs from its market value or its book value, called intrinsic value, which is BioNTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNTech's market value can be influenced by many factors that don't directly affect BioNTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.